←Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Research Milestones
Jedd Wolchok
MD, PhD
🏢Weill Cornell Medicine🌐USA
Meyer Director of the Sandra and Edward Meyer Cancer Center
160
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jedd Wolchok led pivotal trials of ipilimumab and nivolumab combinations that defined modern melanoma immunotherapy. His work established checkpoint blockade as curative for a subset of metastatic melanoma patients. He is one of the founders of modern cancer immunotherapy.
Share:
🧪Research Fields 研究领域
melanoma
immunotherapy
checkpoint blockade
ipilimumab nivolumab
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jedd Wolchok 的研究动态
Follow Jedd Wolchok's research updates
留下邮箱，当我们发布与 Jedd Wolchok（Weill Cornell Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment